Clinical, endoscopic and radiographic outcomes with ustekinumab in medically-refractory Crohn's disease: real world experience from a multicentre cohort.

Christopher MaR N FedorakG G KaplanL A DielemanS M DevlinN SternK I KroekerCynthia H-T SeowY LeungK L NovakB P HalloranV W HuangK WongP K BlusteinS GhoshR Panaccione

Published in: Alimentary pharmacology & therapeutics (2017)

Ustekinumab is an effective therapeutic option for inducing and maintaining clinical, endoscopic and radiographic response in patients with Crohn's disease failing anti-TNF therapy.

Keyphrases

ultrasound guided
clinical trial
type diabetes
mesenchymal stem cells
replacement therapy